More than 2% circulating plasma cells as a prognostic biomarker in a large cohort of patients with newly-diagnosed multiple myeloma.

Mengru TianXinyue LiangWeiling XuXingcheng YiTingting YueYingjie ZhangShanshan YuYurong YanZhongli HuNan ZhangJingxuan WangRui HuXiaoxiao SunYuanyuan NieYun Dai Fengyan Jin

Published in: Annals of hematology (2023)

Keyphrases

newly diagnosed
multiple myeloma
induced apoptosis
cell cycle arrest
cell death
cell proliferation